Seeing Is Believing
Currently out of the existing stock ratings of Edward White, 409 are a BUY (94.68%), 22 are a HOLD (5.09%), 1 are a SELL (0.23%).
Analyst Edward White, carries an average stock price target met ratio of 27.47% that have a potential upside of 49.93% achieved within 120 days. Previously, Edward White worked at HC WAINWRIGHT.
Edward White’s has documented 812 price targets and ratings displayed on 39 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CGEM, Cullinan Oncology LLC at 16-Apr-2025.
Analyst best performing recommendations are on SBTX (SILVERBACK THERAPEUTICS ).
The best stock recommendation documented was for MRTX (MIRATI THER) at 11/15/2017. The price target of $17 was fulfilled within 1 day with a profit of $2.95 (21%) receiving and performance score of 209.96.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 24-Oct-2024
$4.25
$-0.09 (-2.07%)
$4.25
1 years 1 months 30 days ago
(08-Nov-2024)
1/5 (20%)
$-0.11 (-2.52%)
148
Buy
2 years 27 days ago
(10-Dec-2023)
0/1 (0%)
$12.65 (172.11%)
Buy
Since 02-Dec-2020
$10
$5.66 (130.41%)
$10
2 years 4 months 16 days ago
(22-Aug-2023)
1/4 (25%)
$7.03 (236.70%)
28
Hold
Since 08-Dec-2022
$7
$2.66 (61.29%)
$7
3 years 30 days ago
(08-Dec-2022)
2/4 (50%)
$2.8 (66.67%)
79
Buy
Since 01-May-2020
$26
3 years 1 months 24 days ago
(14-Nov-2022)
2/5 (40%)
$17.95 (222.98%)
182
What Year was the first public recommendation made by Edward White?